{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:08:17Z","timestamp":1782950897265,"version":"3.54.5"},"reference-count":47,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cyclic thrombocytopenia (CTP) is a rare disease, which is characterized by periodic fluctuation of the platelet count. The pathogenesis of CTP is unknown and most likely heterogeneous. Patients with CTP are almost always misdiagnosed as having primary immune thrombocytopenia (ITP). The interval between ITP and CTP diagnosis can be many years. CTP patients often receive ITP-specific therapies including corticosteroids, thrombopoietin receptor agonists, rituximab, and splenectomy, which are followed by a transient increase in platelet count that is wrongly attributed to treatment effect with inevitable \u201crelapse.\u201d CTP can be diagnosed by frequent platelet count monitoring, which reveals a typical pattern of periodic platelet cycling. An early diagnosis of CTP will prevent these patients from being exposed to possibly harmful therapies. The bleeding phenotype is usually mild and consists of mucocutaneous bleeding at the time when the platelet count is at its nadir. Severe bleeding from other sites can occur but is rare. Some patients respond to cyclosporine A or to danazol, but most patients do not respond to any therapy. CTP can be associated with hematological malignancies or disorders of the thyroid gland. Nevertheless, spontaneous remissions can occur, even after many years.<\/jats:p>","DOI":"10.1182\/blood.2020008218","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T22:01:20Z","timestamp":1605564080000},"page":"178-184","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["How I manage cyclic thrombocytopenia"],"prefix":"10.1182","volume":"137","author":[{"given":"Paul A.","family":"Kyrle","sequence":"first","affiliation":[{"name":"Department of Medicine I, Medical University of Vienna, Vienna, Austria; and"},{"name":"Karl Landsteiner Institute of Thrombosis Research, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1135-4878","authenticated-orcid":false,"given":"Sabine","family":"Eichinger","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Medical University of Vienna, Vienna, Austria; and"},{"name":"Karl Landsteiner Institute of Thrombosis Research, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"25","key":"2021011416210444600_B1","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/bloodadvances.2017010942","article-title":"Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry","volume":"1","author":"Arnold","year":"2017","journal-title":"Blood Adv"},{"issue":"5667","key":"2021011416210444600_B2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bmj.3.5667.397","article-title":"Cyclic thrombocytopenia associated with multiple autoantibodies","volume":"3","author":"Brey","year":"1969","journal-title":"BMJ"},{"issue":"4","key":"2021011416210444600_B3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2141.1989.tb06312.x","article-title":"Menstrual cyclic thrombocytopenia","volume":"71","author":"Tomer","year":"1989","journal-title":"Br J Haematol"},{"issue":"2","key":"2021011416210444600_B4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJM198907133210207","article-title":"Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor","volume":"321","author":"Hoffman","year":"1989","journal-title":"N Engl J Med"},{"issue":"6","key":"2021011416210444600_B5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.V73.6.1561.1561","article-title":"Cyclic thrombocytopenia of apparent autoimmune etiology","volume":"73","author":"Menitove","year":"1989","journal-title":"Blood"},{"issue":"2","key":"2021011416210444600_B6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ajh.2830360213","article-title":"Danazol therapy for cyclic thrombocytopenia","volume":"36","author":"Rocha","year":"1991","journal-title":"Am J Hematol"},{"issue":"3","key":"2021011416210444600_B7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000204510","article-title":"Periodic production of antiplatelet autoantibody directed against GPIIIa in cyclic thrombocytopenia","volume":"89","author":"Yanabu","year":"1993","journal-title":"Acta Haematol"},{"issue":"4","key":"2021011416210444600_B8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2141.1994.tb05121.x","article-title":"Cyclic thrombocytopenia associated with IgM anti-GPIIb-IIIa autoantibodies","volume":"88","author":"Kosugi","year":"1994","journal-title":"Br J Haematol"},{"issue":"1","key":"2021011416210444600_B9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.1995.tb05267.x","article-title":"Megakaryopoiesis in patients with cyclic thrombocytopenia","volume":"91","author":"Nagasawa","year":"1995","journal-title":"Br J Haematol"},{"issue":"1","key":"2021011416210444600_B10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2141.1996.d01-1783.x","article-title":"Cyclic change of cytokines in a patient with cyclic thrombocytopenia","volume":"94","author":"Kimura","year":"1996","journal-title":"Br J Haematol"},{"issue":"4","key":"2021011416210444600_B11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1096-8652(199712)56:4<272::AID-AJH13>3.0.CO;2-B","article-title":"Cyclic thrombocytopenia in a patient treated with cyclosporine for refractory idiopathic thrombocytopenic purpura","volume":"56","author":"Shirota","year":"1997","journal-title":"Am J Hematol"},{"issue":"2","key":"2021011416210444600_B12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2141.1999.01351.x","article-title":"Relationship between megakaryocyte mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura","volume":"105","author":"Zent","year":"1999","journal-title":"Br J Haematol"},{"issue":"3","key":"2021011416210444600_B13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ajh.1181","article-title":"Cyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapy","volume":"68","author":"Rice","year":"2001","journal-title":"Am J Hematol"},{"issue":"4","key":"2021011416210444600_B14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ajh.20375","article-title":"Large granular lymphocytic proliferation-associated cyclic thrombocytopenia","volume":"79","author":"Fogarty","year":"2005","journal-title":"Am J Hematol"},{"issue":"4","key":"2021011416210444600_B15","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.3324\/haematol.2019.237909","article-title":"Clinical and laboratory characteristics of cyclic thrombocytopenia: an observational study","volume":"105","author":"Steinbrecher","year":"2020","journal-title":"Haematologica"},{"issue":"4","key":"2021011416210444600_B16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1365-2141.1993.tb03214.x","article-title":"Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function","volume":"85","author":"Balduini","year":"1993","journal-title":"Br J Haematol"},{"issue":"1","key":"2021011416210444600_B17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2141.1989.tb00232.x","article-title":"Cyclic idiopathic pure acquired amegakaryocytic thrombocytopenic purpura: a patient treated with cyclosporin A","volume":"73","author":"Telek","year":"1989","journal-title":"Br J Haematol"},{"issue":"3","key":"2021011416210444600_B18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.1991.tb08585.x","article-title":"Cell-mediated cyclic thrombocytopenia treated with azathioprine","volume":"77","author":"Dan","year":"1991","journal-title":"Br J Haematol"},{"issue":"7","key":"2021011416210444600_B19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2169\/internalmedicine.34.636","article-title":"Synchronous fluctuation of interleukin-6 and platelet count in cyclic thrombocytopenia and thrombocytosis","volume":"34","author":"Kuyama","year":"1995","journal-title":"Intern Med"},{"issue":"3","key":"2021011416210444600_B20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<225::AID-AJH10>3.0.CO;2-S","article-title":"Danazol therapy in cyclic acquired amegakaryocytic thrombocytopenic purpura: a case report","volume":"60","author":"Kashyap","year":"1999","journal-title":"Am J Hematol"},{"issue":"1","key":"2021011416210444600_B21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00277-002-0580-2","article-title":"Cyclic thrombocytopenia and polycythemia vera","volume":"82","author":"Kojima","year":"2003","journal-title":"Ann Hematol"},{"issue":"4","key":"2021011416210444600_B22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1365-2141.2002.03951.x","article-title":"Clonal T cell-mediated cyclic thrombocytopenia","volume":"119","author":"F\u00fcreder","year":"2002","journal-title":"Br J Haematol"},{"issue":"3","key":"2021011416210444600_B23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/jcp.27.3.242","article-title":"Cyclic thrombocytopenia: a thrombopoietin deficiency?","volume":"27","author":"Lewis","year":"1974","journal-title":"J Clin Pathol"},{"issue":"11","key":"2021011416210444600_B24","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1182\/blood.V87.11.4918a.bloodjournal87114918a","article-title":"Serum thrombopoietin levels in cyclic thrombocytopenia [letter]","volume":"87","author":"Oh","year":"1996","journal-title":"Blood"},{"issue":"4","key":"2021011416210444600_B25","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1182\/blood.V96.4.1582","article-title":"Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera","volume":"96","author":"Tefferi","year":"2000","journal-title":"Blood"},{"issue":"6","key":"2021011416210444600_B26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/10428190127504","article-title":"Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review","volume":"42","author":"Steensma","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2021011416210444600_B27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12185-009-0415-1","article-title":"Fluctuations in thrombopoietin, immature platelet fraction, and glycocalicin levels in a patient with cyclic thrombocytopenia","volume":"90","author":"Yujiri","year":"2009","journal-title":"Int J Hematol"},{"issue":"7","key":"2021011416210444600_B28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ajh.21435","article-title":"Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients","volume":"84","author":"Bose","year":"2009","journal-title":"Am J Hematol"},{"issue":"1","key":"2021011416210444600_B29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ajh.22186","article-title":"Cyclic thrombocytopenia associated with marked rebound thrombocytosis and fluctuating levels of endogenous thrombopoietin and reticulated platelets: a case report","volume":"87","author":"Connor","year":"2012","journal-title":"Am J Hematol"},{"issue":"22","key":"2021011416210444600_B30","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.1376.1376","article-title":"Identification of a novel MPL loss of function mutation in a patient with cyclic thrombocytopenia and characterization of this syndrome [abstract]","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2021011416210444600_B31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ajh.2830480117","article-title":"Cyclic thrombocytopenia successfully treated with low dose hormonal contraception","volume":"48","author":"Helleberg","year":"1995","journal-title":"Am J Hematol"},{"issue":"3","key":"2021011416210444600_B32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5152\/tjh.2010.28","article-title":"Cyclic thrombocytopenia: a case report [in Turkish]","volume":"27","author":"\u015eumnu","year":"2010","journal-title":"Turk J Haematol"},{"issue":"10","key":"2021011416210444600_B33","first-page":"3595","article-title":"Cyclic thrombocytopenia related to menstrual cycle: a case report and literature review","volume":"7","author":"Chen","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"2021011416210444600_B34","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3324\/haematol.2010.022178","article-title":"Hydroxyurea induced oscillations in twelve patients with polycythemia vera","volume":"95","author":"Tauscher","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"2021011416210444600_B35","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/trf.14513","article-title":"Adult-onset primary cyclic autoimmune neutropenia: a case report","volume":"58","author":"Yabushita","year":"2018","journal-title":"Transfusion"},{"issue":"6","key":"2021011416210444600_B36","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.hoc.2009.08.003","article-title":"Thyroid disease in patients with immune thrombocytopenia","volume":"23","author":"Cheung","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"2021011416210444600_B37","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood.V92.8.2629","article-title":"Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models","volume":"92","author":"Haurie","year":"1998","journal-title":"Blood"},{"issue":"4","key":"2021011416210444600_B38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/70544","article-title":"Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis","volume":"23","author":"Horwitz","year":"1999","journal-title":"Nat Genet"},{"issue":"3","key":"2021011416210444600_B39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/bjh.14677","article-title":"How I manage children with neutropenia","volume":"178","author":"Dale","year":"2017","journal-title":"Br J Haematol"},{"issue":"1","key":"2021011416210444600_B40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.blre.2004.05.001","article-title":"Idiopathic cyclic thrombocytopenia","volume":"19","author":"Go","year":"2005","journal-title":"Blood Rev"},{"issue":"suppl 5","key":"2021011416210444600_B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000492187","article-title":"Immune thrombocytopenia - current diagnostics and therapy: recommendations of a Joint Working Group of DGHO, \u00d6GHO, SGH, GPOH, and DGTI","volume":"41","author":"Matzdorff","year":"2018","journal-title":"Oncol Res Treat"},{"issue":"23","key":"2021011416210444600_B42","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia [published correction appears in Blood Adv. 2020;4(2):252]","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"22","key":"2021011416210444600_B43","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"issue":"7","key":"2021011416210444600_B44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood.2019003599","article-title":"Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment [published correction appears in Blood. 2020;135(25):2325]","volume":"135","author":"Miltiadous","year":"2020","journal-title":"Blood"},{"key":"2021011416210444600_B45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/asheducation-2018.1.561","article-title":"How do we diagnose immune thrombocytopenia in 2018?","volume":"2018","author":"Kelton","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"2021011416210444600_B46","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"2021011416210444600_B47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0609.1967.tb01640.x","article-title":"Cyclic thrombocytopenia of acute type","volume":"4","author":"Wasastjerna","year":"1967","journal-title":"Scand J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/2\/178\/1797393\/bloodbld2020008218c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/2\/178\/1797393\/bloodbld2020008218c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T16:32:00Z","timestamp":1610641920000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/137\/2\/178\/474179\/How-I-manage-cyclic-thrombocytopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020008218","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,14]]}}}